A monofunctional derivative of melphalan: Preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts

Chemical Research in Toxicology

Volumn 11, Issue 10, 1998, Pages 1162-1168

  Tilby, Michael J ^a,d   McCartney, Hazel ^a   Gould, Katherine A ^a   O'Hare, C Caroline ^b   Hartley, John A ^b   Hall, Andrew G ^a   Golding, Bernard T ^b   Lawley, Philip D ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CHLORMETHINE DERIVATIVE; DNA; DNA BASE; GUANINE; MELPHALAN; MONOCLONAL ANTIBODY;

ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; DNA ADDUCT; DNA ALKYLATION; DNA CROSS LINKING; DNA DAMAGE; DNA MODIFICATION; DRUG CYTOTOXICITY; DRUG DNA INTERACTION;

EID: 0031769465     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980129a     Document Type: Article

References (28)

1. International Agency for Research on Cancer (1987) IARC monographs on the evaluation of carcinogenic risks to humans. Supplement 7, pp 39-43, International Agency for Research on Cancer, Lyon, France.
2. Lawley, P. D., and Philips, D. H. (1996) DNA adducts from chemotherapeutic agents. Mutat. Res. 355, 13-40.
3. Peckham, M., Pinedo, B., and Veronesi, U., Eds. (1995) Oxford textbook of oncology, Oxford University Press, Oxford, U.K.
4. Springer, C. J., Antoniw, P., Bagshawe, K. D., Searle, F., and Bisset, G. M. F. (1990) Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2. J. Med. Chem. 33, 677-681.
5. Blakey, D. C., Burke, P. J., Davies, D. H., Dowell, R. I., East, S. J., Eckersley, K. P., Fitton, J. E., McDaid, J., Melton, R. G., Niculescu-Duvaz, I. A., Pinder, P. E., Sharma, S. K., Wright, A. F., and Springer, C. J. (1996) ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal xenografts. Cancer Res. 56, 3287-3292.
6. Melton, R. G., and Sherwood, R. F. (1996) Antibody-enzyme conjugates for cancer therapy. J. Natl. Cancer Inst. 88, 153-165.
7. Connors, T. A. (1995) The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Ther. 2, 702-709.
8. Blakey, D. C., Davies, D. H., Dowell, R. L. East, S. J., Burke, P. J., Sharma, S. K., Springer, C. J., Mauger, A. B., and Melton, R. G. (1995) Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs. Br. J. Cancer 72, 1083-1088.
9. Tilby, M. J., Styles, J. M., and Dean, C. J. (1987) Immunological detection of DNA damage caused by melphalan using monoclonal antibodies. Cancer Res. 47, 1542-1546.
10. Tilby, M. J., McCartney, H., Cordell, J., Frank, A. J., and Dean, C. J. (1995) A monoclonal antibody that recognises alkalistabilised melphalan-DNA adducts and its application in immunofluorescence microscopy. Carcinogenesis 16, 1895-1901.
11. Tilby, M. J., Newell, D. R., Viner, C., Selby, P. J., and Dean, C. J. (1993) Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapy. Eur. J. Cancer 29A, 681-686.
12. Frank, A. J., Proctor, S. J., and Tilby, M. J. (1996) Detection and quantification of melphalan-DNA adducts at the single cell level in hemopoietic tumor cells. Blood 88, 977-984.
13. Tilby, M. J., Lawley, P. D., and Farmer, P. B. (1990) Alkylation of DNA by melphalan in relation to immunoassay of melphalanDNA adducts: characterization of mono-alkylated and crosslinked products from reaction of melphalan with dGMP and GMP. Chem.-Biol. Interact. 73, 183-194.
14. Osborne, M. R., and Lawley, P. D. (1993) Alkylation of DNA by melphalan with special reference to adenine derivatives and adenine-guanine cross-linking. Chem.-Biol. Interact. 89, 49-60.
15. Osborne, M. R., Lawley, P. D., Crofton-Sleigh, C., and Warren, W. (1995) Products from alkylation of DNA in cells by melphalan: human soft tissue sarcoma cell line RD and Escherichia coli WP2. Chem.-Biol. Interact. 97, 287-296.
16. Povirk, L. F., and Shuker, D. E. (1994) DNA damage and mutagenesis induced by nitrogen mustards. Mutat. Res. 318, 205-226.
17. Ross, W. C. J. (1962) Biological alkylating agents, Butterworth, London.
18. Connors, T. A., Ross, W. C. J., and Wilson, J. G. (1960) Aryl-2-halogenoalkylamines. Part XDC. Some N,N-di-2-chloroethylamino-phenyl- and -phenylalkyl-hydantoins and related amino-acids. J. Chem. Soc., 2994-3007.
19. Burchenal, J. H., Lester, R. A., Riley, J. B., and Rhoads, C. P. (1948) Studies on the chemotherapy of leukemia. Cancer 1, 399-412.
20. Burchenal, J. H., Burchenal, J. R., and Johnston, S. F. (1951) Chemotherapy of leukemia. III. Further studies on the effect of nitrogen mustards and related compounds on transmitted mouse leukemia. Cancer 4, 353-356.
21. Bergel, F., and Stock, J. A. (1959) Cyto-active amino-acids and peptides. Part V. Derivatives of p-amino- and p-mercapto-phenylalanine. J. Chem. Soc., 90-97.
22. Gould, K. A., McCartney, H., Lawley, P. D., Golding, B. T., and Tilby, M. J. (1997) Specificity of p53 elevation and its role in drug action: p53 induction by measured levels of specific DNA adducts. Proc. Am. Assoc. Cancer Res. 38, 2.
23. Ponti, M., Forrow, S. M., Souhami, R. L., D'Incalci, M., and Hartley, J. A. (1991) Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Res. 19, 2929-2933.
24. Mattes, W. B., Hartley, J. A., and Kohn, K. W. (1986) DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucleic Acids Res. 14, 2971-2987.
25. Ducore, J. M., Erickson, L. C., Zwelling, L. A., Laurent, G., and Kohn, K. W. (1982) Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cisdiamminedichloroplatinum(II) and L-phenylalanine mustard. Cancer Res. 42, 897-902.
26. Osborne, M. R., and Lawley, P. D. (1992) The reaction of melphalan with deoxyguanosine and deoxyguanylic acid. Chem.Biol. Interact. 84, 189-198.
27. Haddow, A., Kon, G. A. R., and Ross, W. C. J. (1948) Effects upon tumours of various haloalkylarylamines. Nature 162, 824-825.
28. Bosanquet, A. G., and Bird, M. C. (1988) Degradation of melphalan in vitro: rationale for the use of continuous exposure in chemosensitivity assays. Cancer Chemother. Pharmacol. 21, 211-215.